# A Study of CK-1827452 Infusion in Stable Heart Failure

> **NCT00624442** · PHASE2 · COMPLETED · sponsor: **Cytokinetics** · enrollment: 45 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** CK-1827452
- **DRUG:** CK-1827452
- **DRUG:** CK-1827452
- **DRUG:** CK-1827452
- **DRUG:** CK-1827452
- **DRUG:** CK-1827452
- **DRUG:** CK-1827452
- **DRUG:** CK-1827452
- **DRUG:** Placebo
- **DRUG:** Placebo
- **DRUG:** CK-1827452
- **DRUG:** Placebo
- **DRUG:** CK-1827452
- **DRUG:** CK-1827452
- **DRUG:** CK-1827452
- **DRUG:** CK-1827452

## Key facts

- **NCT ID:** NCT00624442
- **Lead sponsor:** Cytokinetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2021-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00624442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00624442, "A Study of CK-1827452 Infusion in Stable Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00624442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*